Latest News in the pharma Industry
Research & Development
Pfizer receives expanded Health Canada approval for Ibrance in HR+, HER2- metastatic breast cancer
25 Jun 2017
New indication supported by results of Phase III PALOMA-3 Trial of Ibrance in combination with fulvestrant.
Read more
Biogen’s Imraldi, an adalimumab biosimilar candidate referencing Humira, granted positive opinion by CHMP
23 Jun 2017
If approved, Imraldi will be the third anti-TNF biosimilar in Biogen’s portfolio in Europe.
Read more
Novartis achieves regulatory milestone for AMG 334 in migraine prevention with EMA filing acceptance
21 Jun 2017
AMG 334 (erenumab) is the first anti-CGRP monoclonal antibody developed for migraine prevention to receive EMA regulatory filing acceptance.
Read more
FDA accepts Amgen's sBLA to expand indication for Xgeva to include multiple myeloma patients
19 Jun 2017
Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumours and is the number one prescribed agent by oncologists for this indication in the US.
Read more
Merck presses the pause button on Keytruda trials
16 Jun 2017
The pause is to allow for additional information to be collected to better understand more reports of death in the Keytruda groups.
Read more
Parexel and Sanofi collaborate to advance the use of wearable devices in life science industry
15 Jun 2017
Preliminary findings from pilot study validate use of wearable technologies to collect data and manage clinical trials more effectively and efficiently.
Read more
Lilly's Taltz shows promise for patients with active psoriatic arthritis
15 Jun 2017
Demonstrated significant improvements in disease signs and symptoms at 24 weeks among patients with active psoriatic arthritis who had prior inadequate response or intolerance to TNF inhibitors.
Read more
LifeArc, previously MRC Technology, set to transform the medical research landscape
15 Jun 2017
Investment will focus on new innovations in therapeutics for neurodegeneration, antibiotic resistance, cancer and respiratory diseases.
Read more
Irvine Scientific adds new Center of Excellence for R&D
14 Jun 2017
Company adds fifth building in Southern California.
Read more
Successful Phase III top-line results with Bekinda for acute gastroenteritis
14 Jun 2017
Study successfully met its primary endpoint and Bekinda 24 mg was shown to be effective, safe and well tolerated in patients with acute gastroenteritis and gastritis.
Read more
Achelios Therapeutics concludes successful Type C meeting with FDA regarding Topofen
14 Jun 2017
Currently there are no approved topical NSAIDs indicated for the treatment of migraine.
Read more
Lilly's galcanezumab significantly reduces number of migraine headache days
12 Jun 2017
New results presented at AHS.
Read more